Cardiac glycosides Flashcards
Cardio-tonic drugs
Cardio_________ drugs (also called “cardiotonic drugs”)
stimulatory
Cardio-tonic drugs
Enhance cardiac function by
– increasing heart rate (_____tropy)
– myocardial contractility (___tropy),
– May increase electrical conduction (_______tropy) within the heart and
– augment relaxation (_____tropy).
chrono
ino
dromo
lusi
Cardio-tonic drugs
The cardiac effects of these drugs make them suitable for
–____ failure
–________ shock
– ______tension.
Heart
Cardiogenic
hypo
Classes of Cardiostimulatory Drugs
________
____________
________________
____________
Beta-agonists
Digitalis compounds
Phosphodiesterase inhibitors PDEI
Calcium sensitizers
Cardiac glycosides are _____ compounds containing a _______(_____) that act on the ____________ of the cardiac muscle.
organic
glycoside (sugar)
contractile force
Cardiac glycosides
Important class of (naturally or artificially ?) occurring drugs whose actions include both ______ and ________ effects on the heart.
naturally
beneficial and toxic
Cardiac glycosides
Found as (primary or secondary?) metabolites in several plants , but also in some _____, such as the __________ ————
secondary
insects
milkweed butterflies.
Chemistry of cardiac glycosides
All of the glycosides of which digoxin is the prototype combine a
–_____ nucleus linked to an unsaturated ____ membered _______ ring at the ____ position
– and a series of _____ at ______ of the nucleus.
steroid; 5 ; lactone; 17
sugars; carbon 3
Chemistry of cardiac glycosides
Because they lack an easily ionizable group, their _____________________________________.
_______ nucleus with ———- ring is essential for myocardial action.
solubility is not pH dependent
Steroid; lactone
CVS effect of Cardiac Glycosides in Heart Failure
Mechanical and Electrical effect
(+ve) ____tropic.
(-ve) _____tropic
→Binding to ———- in the plasma membrane of central & peripheral nervous system → (-) of symp.
ino; chrono
Na pumps
CVS effect of Cardiac Glycosides
its positive inotropic action results in,
– a. increased _______
– b. decreased _________
– c. decreased ____________
– d. decreased ___________________________
– e. _______ and relief of oedema
cardiac output
heart size
venous pressure
circulating blood volume
diuresis
Electrical activity of Cardiac Glycosides
——-eased automaticity of SA node indirectly
_____eased Refractory period of the AV node
____eased Condution Velocity at the AV nodal Tissue
(Stimulate or Depress?) vagal Nerve
Decr
Incr
Decr
Stimulate
Therapeutic uses of Digitalis Compounds
During Heart Failure, to cause:
– ____eased inotropy
– ____eased ejection fraction
– ____eased preload
– ____eased pulmonary congestion/edema
Incr
Incr
Decr
Decr
Therapeutic uses of Digitalis Compounds
Arrhythmias
– ______ease AV nodal conduction (parasympathomimetic effect)
– ____ease ventricular rate in atrial flutter and fibrillation
decr
decr
Contraindications of Digitalis Compounds
•Ventricular Tachycardia - because digitalis _____________ especially at high doses
•——————.
increase automaticity
Heart block
Mechanism of action of Digitalis Compounds
Inhibits the ________, which is responsible for —————- across the muscle cell membrane
Leads to ____eased force of myocardial contraction.
Na+/K+-ATPase
Na+/K+ exchange
Incr
Digoxin and _____ ions compete for a “receptor” (Na+/K+-ATPase) on the (internal or external?) membrane.
So, the effects of digoxin may be dengerously increaseed by ________, produced, for example, by diuretics.
K+
External
hypokalemia
Cardiac glycosides : mechanism of action.
Inhibits _______ pump
Increase intracellular ____ conc.
Inhibits ______ exchangers
Decrease ______ efflux from the cell
Increase intracellular _____
____ease cardiac contractility
Na/K atpase; sodium
Na/Ca2+; calcium; calcium
Incr
Pharmacokinetics of Digoxin
absorption of digoxin after ___ administration ranging from ____-___%.
absorption can be retarded by,
– a. the ______ in the GIT
– b. delayed ________
– c. ______ syndromes
– d. antibiotics, such as ____________
– e. steroid binding _____
oral; 40-90
presence of food
gastric emptying
neomycin
resins
Digoxin:
Oral availability =
Half life =
Elimination is by??
75
40 Hours
Kidneys
Adverse effect of Digoxin
1.Extracardiac
On GIT→ Anorexia, nausea,vomiting Fatigue ,weakness, diarrhoea
Neurological problems ————-,———-
Due to steroid nucleus -_________ in male
blurring of vision, confusion
gynaecomastia
Adverse effect of Digoxin
Cardiac effect:
i)All type of arrythmia (increased ________ in high dose)
ii) Slowing A-V nodal Conduction- _________ ________
Automaticity
Bradycardia Heart block
Drug interaction Pharmacodynamic interaction
_________ + digoxin= ↓ AV Conduction - Heart Block
_________+ digoxin= ↓ AV Conduction –Heart Block
Digitalis+ ____________________ = cause K+ loss
B –blocker
Verapamil
Diuretics(Thiazide/Frusemide)
Drug interaction Pharmacokinetic interaction
Verapamil+ digoxin→_____eased plasma digitalis concentration by ________________________ leading to increased conc. of digoxin →toxicity
incr
competing with digoxin for renal excretion
Drug interaction Pharmacokinetic interaction
Digitalis+Quinidine= ______ digitalis from ___________ , leading to \___eased concentration of digitalis →↑toxicity
displace
tissue binding site
incr
Digoxin Toxicity
________ is earliest symptom
__________ is earliest sign ( if <—— b/min, digitalis not given)
Low Therapeutic Index of ____nmol/L
Anorexia
Bradycardia; 60
1-2.6
Toxicity of digoxin
Treatment: treatment is different in 2 different condition
(i) ________
ii) Monitor ____ level( if ________ administer K+, IV KCL)
Stop the drug
K+ ; hypokalemia
Hypokalemia K+ and digitalis, interact in two ways-
First – hypokaelamia causes ______eases the myocardial localization of digoxin.
(Increase or reduction?) in extracellular K+,
Cause increased _________ of _______.
Digoxin has (lower or higher?) affinity for the phosphorylated form of Na pump.
Second – ___________________ is inhibited by hyperkalemia.
incr
reduction
phosphorylation of Na pump
Higher
abnormal cardiac automaticity
Digoxin Toxicity
Effect of other electrolytes imbalance on digoxin use –
Causing toxicity
– _______calcaemia Ca++,
– _____magnesaemia Mg++
Hyper
Hypo
Ca++ facilitates the toxic actions of cardiac glycosides by _____________________________ that appears to be responsible for digitalis-induced ______________
accelerating the overloading of intracellular Ca++ stores
abnormal automaticity.
______calcemia therefore increases the risk of digitalis induced arrhythmia.
Hyper
Hypomagnesemia
Decreased Mg++ concentration _______________ of cardiac glycosides.
enhances toxicities
Digitalis Toxicity – Use of Antidote
If patient still refractory to treatment –
Antidotes to digoxin
–_________________ (Fab fraction)
– digoxin binding specific antibody ( _________ ) given to _________________
monoclonal antibody
digibind
remove excess digoxin from the body.
HEART FAILURE DRUGS
DRUGS FOR _____________
DRUG FOR ——————
DRUG FOR _____________________
PREVENTING CARDIAC REMODELLING
TREATING SYMPTOM
IMPROVING CONTRACTILITY
Drugs for PREVENTING CARDIAC REMODELLING
LIST !!!!
ACE INHIBITORS
ANGIOTENSIN RECEPTOR BLOCKERS
BETA BLOCKERS
VASODILATORS
Mechanisms of ACE inhibitors
Inhibits ANGIOTENSIN CONVERTING ENZYME
Alters the __________ and _______
Thus prevents cardiac remodeling
Pre-load and Afterload
MECHANISM OF ACTION of ANGIOTENSIN RECEPTOR BLOCKERS
Inhibits Angiotensin II receptor
Alters the __________________
Thus prevents cardiac remodeling
Pre-load and After load
MECHANISM OF ACTION of beta blockers
Inhibits Beta adrenergic receptors
Reduces ________ and ___________
Thus prevents cardiac remodeling
Heart rate and Force of Contraction
MECHANISM OF ACTION of vasodilators
Lead to vasodilation
Alter the _________________
Thus prevents cardiac remodeling
Pre-load and Afterload
CARDIOTONICS
Are
____________,_________, and ______
CARDIAC GLYCOSIDES
BETA 1 AGONIST
PDE INHIBITORS
CARDIAC GLYCOSIDES
_________ type
_______ type
CARDENOLIDE
BUFADINOLIDE
EXAMPLES of cardiac glycosides
• Cardenolide
–_________
–_________
Bufadenolide
– Drimia maritima – Kalanchoe
daigremontianin – Daigremontianin
Digitalis lanata
Digitalis purpura
CARDIAC GLYCOSIDES
•
Made up of a combination of
– _______
– _______
– _______
– Steroid nucleus
– Lactone ring
– Sugar
CARDIAC GLYCOSIDES
Causes _____eased inotropy and ____eased chronotropy
incr
decr
CARDIAC GLYCOSIDES
PHARMACODYNAMICS : Drug Effect
Usually leads to two types of Drug effect
________ effect
_________ effect
Mechanical
Electrical
Cardiac glycosides
Electrical effect
Decreased ___________ indirectly
Increased _________ of the AV node
Decreased _________ at the AV nodal Tissue
Stimulate _______ Nerve
Automaticity of SA node
Refractory period
Conduction Velocity
vagal
CARDIAC GLYCOSIDES are highly toxic
T/F
T
Factors affecting toxicity of cardiac glycosides
__________mia
__________emia
___________emia
Hypercalcemia
Hypomagnesaemia
Hypokalemia
CARDIAC GLYCOSIDES
Extracardiac
–_____ like syndrome
– ______tension
– Headache
– Nausea
– Diarrhea
– Flushing
– Tachycardia
Lupus
Hypo
CARDIAC GLYCOSIDES
ADVERSE EFFECT
Cardiac
– Arrhythmia
•__________ lock
•_______ arrhythmia
• ___________ arrhythmia
Conduction
Atrial
Ventricular
CARDIAC GLYCOSIDES
Treatment
TOXICITY
– Treat arrhythmia
Atrial arrhythmia –_______
Ventricular arrhythmia – _________
Heart block - ___________
Phenytoin
Lignocaine
Atropine
BETA AGONIST
EXAMPLES
Dobutamine
Supplied in ______ mixtures
Increases ____tropy without increasing ______tropy
racemic
Ino
Chrono
BETA AGONIST
EXAMPLES
Dopamine
Given _____
Dose is between 1 to 5 μgm/kg/min
Has a (short or long?) half life of _____________
Metabolized in the _____ by _____
IV
Short
2 to 3 mins
Liver
COMT
BETA AGONIST
MECHANISM OF ACTION
Stimulate to Beta 1 adrenergic receptors in the Heart
Causes increased ______________________
This leads to improvement in the myocardial contractility
INOTROPY
PDE INHIBITOR
Give 3 examples
EXAMPLES
Amrinone
Milrinone
Enoximone
MECHANISM OF ACTION of PDE INHIBITOR
Inhibit Phosphodiesterase enzyme
This causes an
•Increase in _____
•Activation of __________
•Activation of _____________channel
•Increase in _____tropy
cAMP
protein kinase
sarcolemma calcium
ino
__________ represent the newest class of cardiostimulatory drugs.
Calcium sensitizing drugs
Calcium sensitizing drugs
These drugs increase the _________________ so that more calcium becomes bound to troponin-C, which enhances contractility.
At present, these drugs are ___________________________, and therefore not yet approved.
sensitivity of troponin-C for calcium
under clinical investigation for heart failure
With dobutamine, there is increase in cardiac workload
T/F
F
Decrease
Dobutamine does not activate dopaminergic receptors.
T/F
T
__________ is the preferred beta agonist for the management of patients with end-stage systolic dysfunction and CHF.
Dobutamine
Dobutamine is supplied as a racemic mixturethat stimulates ___________ receptor subtypes.
both b1 and b2
Dobutamine
In addition, the (–) enantiomer is ______ for a adrenergic receptors, whereas the (+) enantiomer is a ___________
an agonist
very weak partial agonist.
DA has limited utility in the treatment of most patients with cardiogenic circulatory failure.
T/F
T
Dopamine
At low doses (≤—— μg/kg lean body mass per minute)
DA causes vaso_____ by stimulating _______ receptors on smooth muscle
Also by stimulating presynaptic ____ receptors on sympathetic nerves in the peripheral circulation(___________ and reducing __________ stimulation of vascular smooth muscle); thesereceptors are prominent in ______ and _________ arterial beds
2
dilation; dopaminergic
D2
inhibiting NE release ; a adrenergic
splanchnic and renal
Dopamine
At intermediate infusion rates (_____ μg/kg/min),
DA directly stimulates _____ receptors on the _____ and vascular sympathetic neurons, enhancing cardiac contractility and neural NE release.
2–5
Beta; heart
Dopamine
At higher infusion rates (_____ μg/kg/min),
peripheral arterial and venous _______ occur, mediated by _______ receptor stimulation.
5–15
constriction
a adrenergic
Tachycardia is more pronounced with dobutamine than with dopamine
T/F
F
Tachycardia, which is more pronounced with DA than with dobutamine, may provoke ischemia in patients with coronary artery disease.
Dopamine
it is a drug of choice.(T/F)
Very (short or long?) half life ( _______)
T
Short
2- 3minutes